SPOTLIGHT: Bradley licenses experimental gel


Bradley Pharmaceuticals has agreed to license BioSante's experimental gel for hot flashes for $3.5 million up front and up to $10.5 million in milestones. The FDA is expected to issue a final ruling on Bio-E-Gel in December. Article